RCUS
Arcus Biosciences·NYSE
--
--(--)
--
--(--)
5.28 / 10
Netural
Analyst sentiment is bullish with 66.7% Strong Buy and 33.3% Buy, though track records are mixed. Fund‑flow rating is good (7.48), showing inflows for small, medium and large investors but outflows for block and extra‑large, indicating uneven buying pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-02
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of RCUS?
- RCUS holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.28/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
